Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P489: Rescue treatment with original versus biosimilar infliximab in biologic-naïve patients with moderate-severe Ulcerative Colitis and corticosteroid failureECCO'21 Virtual
Year: 2021
Authors: Muñoz-Villafranca, C.(1);Ogueta, M.Á.(2);Ramírez de la Piscina, P.(2);Álvarez-Herrero, B.(2);Loizate, A.(3);Gómez-Zabala, J.M.(3);De La Maza-Ortiz, S.(1);Aresti, U.(4);Gorostiza, I.(4);Arreba, P.(1);Irigoyen, M.(5);Ortiz de Zárate, J.(1);
(1)Hospital Universitario de Basurto, Gastroenterology Department, Bilbao, Spain;(2)Hospital Universitario Araba, Gastroenterology Department, Vitoria, Spain;(3)Hospital Universitario Basurto, Surgery Department, Bilbao, Spain;(4)Hospital Universitario Basurto, Investigation Department, Bilbao, Spain;(5)Hospital Universitario Príncipe de Asturias, Internal Medicine Department, Alcalá de Henares, Spain
P490: The impact of the COVID-19 pandemic on gastroenterologists providing care to inflammatory bowel disease patients in Canada: preliminary data of a cross-sectional surveyECCO'21 Virtual
Year: 2021
Authors: Mikail, M.(1);Malhi, G.(1);Wilson, A.(2);Khanna, R.(3);
(1)Western University, Schulich School of Medicine & Dentistry - Department of Medicine, London, Canada;(2)Western University, Schulich School of Medicine & Dentistry - Department of Gastroenterology- Division of Clinical Pharmacology and Department of Physiology & Pharmacology, London, Canada;(3)Western University, Schulich School of Medicine & Dentistry - Department of Gastroenterology, London, Canada
P491: Infectious risk of vedolizumab compared with other biological agents in the treatment of Inflammatory Bowel DiseaseECCO'21 Virtual
Year: 2021
Authors: Innocenti, T.(1,2);Roselli, J.(1,2);Lynch, E.N.(1,2);Apolito, P.(1,2);Parisio, L.(1,2);Bagnoli, S.(2);Macrì, G.(2);Rogai, F.(2);Milani, S.(1);Galli, A.(1);Milla, M.(2);Dragoni, G.(1,2,3);
(1)University of Florence, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio”, Florence, Italy;(2)Azienda Ospedaliero Universitaria Careggi, IBD Referral Centre, Florence, Italy;(3)University of Siena, Department of Medical Biotechnologies, Siena, Italy
P492: The UC Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A prospective open label pilot studyECCO'21 Virtual
Year: 2021
Authors: Sarbagili Shabat, C.(1,2);Albenberg, L.(3);Van Limbergen, J.(4,5);Otley, A.(6);Yaakov, M.(1);Wine, E.(7);Weiner, D.(1);Levine, A.(1,2);
(1)Edith Wolfson Medical Center, PIBD Research center- Paediatric Gastroenterology and Nutrition Unit, Holon, Israel;(2)Tel-Aviv University, The Sackler Faculty of Medicine, Tel-Aviv, Israel;(3)Children’s Hospital of Philadelphia, Division of Gastroenterology- Hepatology- and Nutrition, Philadelphia- Pennsylvania, United States;(4)Amsterdam University Medical Centers, Emma Children’s Hospital, Amsterdam, The Netherlands;(5)University of Amsterdam, Tytgat Institute for Liver and Intestinal Research- Amsterdam Gastroenterology and Metabolism- Academic Medical Center, Amsterdam, The Netherlands;(6)IWK Health Center, Division of Gastroenterology and Nutrition, Halifax, Canada;(7)University of Alberta, Departments of Pediatrics and Physiology, Edmonton- Alberta, Canada
P493: Cost-effectiveness of venous thromboembolism prophylaxis after hospitalization in patients with Inflammatory Bowel DiseaseECCO'21 Virtual
Year: 2021
Authors: Lee, K.(1);Lim, F.(2);Colombel, J.F.(3);Hur, C.(2);Faye, A.(3);
(1)Columbia University Vagelos College of Physicians and Surgeons, Medicine- Division of Digestive and Liver Diseases, New York, United States;(2)Columbia University Irving Medical Center, Medicine- Division of Digestive and Liver Diseases, New York, United States;(3)Icahn School of Medicine at Mt. Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States
P494: Can Patients Monitor Response To Ustekinumab In The Real World?ECCO'21 Virtual
Year: 2021
Authors: Walsh, A.J.(1);Matini, L.(1);Kormilitzin, A.(2);Wilson, J.(1);Lyden, S.(1);Al-Hillawi, L.(1);Kantschuster, R.(1);White, L.(1);Payton, S.(1);Brain, O.(1);Palmer, R.(1);Ambrose, T.(1);Satsangi, J.(1);Travis, S.P.L.(1);
(1)Oxford University Hospitals NHS Foundation Trust, Translational Gastroenterology Unit, Oxford, United Kingdom;(2)University of Oxford, Mathematical Institute, Oxford, United Kingdom
P495: The interplay of biopsychosocial factors and quality of life in Inflammatory Bowel Diseases: a network analysisECCO'21 Virtual
Year: 2021
Authors: Knödler, L.L.(1);Thomann, A.(1);Karthikeyan, S.(2);Atanasova, K.(3);Bernstein, C.(4);Ebert, M.(1);Lis, S.(3);Reindl, W.(1);
(1)University Medical Center Mannheim- Medical Faculty Mannheim- Heidelberg University, Department of Medicine II, Mannheim, Germany;(2)Institute of Psychiatric and Psychosomatic Psychotherapy- Medical Faculty Mannheim- Heidelberg University- Central Institute of Mental Health- Mannheim- Germany, Experimental Psychology, , Germany;(3)Institute of Psychiatric and Psychosomatic Psychotherapy- Medical Faculty Mannheim- Heidelberg University- Central Institute of Mental Health- Mannheim- Germany, Experimental Psychology, Mannheim, Germany;(4)Faculty of Medicine- University of Manitoba- Winnipeg- MP- Canada, Department of Gastroenterology, Winnipeg, Canada
P496: Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort studyECCO'21 Virtual
Year: 2021
Authors: Smith, P.J.(1);Storey, D.(1);Gregg, B.(1);Critchley, L.(1);Stenson, J.(1);Kneebone, A.(1);Rimmer, T.(1);Burke, S.(1);Hussain, S.(2);Teoh, W.Y.(2);Vazeille, S.(2);Serna, S.(3);Bond, A.(1);Steel, A.(1);Dibb, M.(1);Collins, P.(1);Derbyshire, E.(1);Bodger, K.(1);Probert, C.(1);Verma, A.(3);Subramanian, S.(1);
(1)Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom;(2)Liverpool School of Medicine, University of Liverpool, Liverpool, United Kingdom;(3)Department of Gastroenterology, Kettering General Hospital, Kettering, United Kingdom
P497: The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn’s diseaseECCO'21 Virtual
Year: 2021
Authors: Kantasiripitak, W.(1);Mathôt, R.(2);Oldenburg, B.(3);Buisson, A.(4);Ferrante, M.(5,6);Laharie, D.(7);D’Haens, G.(8);Vermeire, S.(5,6);Dreesen, E.(1,9);
(1)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(2)Amsterdam UMC, Hospital Pharmacy, Amsterdam, The Netherlands;(3)University Medical Centre, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(4)Estaing University Hospital, Department of Gastroenterology, Clermont-Ferrand, France;(5)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(6)KU Leuven, Department of Chronic Diseases Metabolism and Ageing, Leuven, Belgium;(7)Haut-Lévêque Hospital, Department of Hepato-gastroenterology and Digestive Oncology Bordeaux UMC, Bordeaux, France;(8)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(9)Uppsala University, Department of Pharmacy, Uppsala, Sweden
P498: Diagnosing and differentiating iron deficiency in inflammatory disorders: still an unsolved mystery?ECCO'21 Virtual
Year: 2021
Authors: Aksan, A.(1,2);Aksan, S.(1,3);Farrag, K.(1);Schröder, O.(1,3);Stein, J.M.(1,3,4);
(1)Interdisciplinary Crohn Colitis Centre Rhein-Main, Clinical Research, Frankfurt am Main, Germany;(2)Justus-Liebig University Giessen, Institute of Nutritional Science, Giessen, Germany;(3)DGD Clinics Frankfurt-Sachsenhausen, Gastroenterology and Clinical Nutrition, Frankfurt am Main, Germany;(4)Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, Frankfurt am Main, Germany
P499: Use of an Inflammatory Bowel Disease illustrated guide as a patient education toolECCO'21 Virtual
Year: 2021
Authors: Murray, J.(1);Lindsay, J.(1);
(1)Royal London Hospital- Barts Health NHS Trust- London, Department of Gastroenterology, London, United Kingdom
P500: Assessing physical activity, fatigue and quality of life in an outpatient cohort of IBD patientsECCO'21 Virtual
Year: 2021
Authors: Janssen , L.M.(1,2);Hendrix, E.M.B.(1,2);Spooren , C.E.G.M.(1,2);Stassen , L.P.S.(2,3);Pierik , M.J.(1,2);Jonkers , D.M.A.E.(1,2);
(1)Department of Internal Medicine Division of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, The Netherlands;(2)School for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht University, Maastricht, The Netherlands;(3)Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands
P501: Incidence and therapeutic management/treatment of very early onset inflammatory bowel disease during 2015-2020.ECCO'21 Virtual
Year: 2021
Authors: Ninh, G.(1);Wewer, V.(1);Jakobsen, C.(1);
(1)Copenhagen University Hospital- Hvidovre, Department of Pediatrics, Hvidovre, Denmark
P502: Dietary habits and nutritional status in children and adolescents with Inflammatory Bowel Disease: an italian multicenter case-control study (NUTRIBD study)ECCO'21 Virtual
Year: 2021
Authors: Gatti, S.(1);Vallorani, M.(1);zoppi, E.(1);aloi, M.(2);bramuzzo, M.(3);felici, E.(4);panceri, R.(5);ciacchini, B.(6);catassi, G.(2);grazian, F.(3);catassi, C.(1);
(1)Polytechnic University of Marche, clinica pediatrica, Ancona, Italy;(2)Università la Sapienza di Roma-, Dipartimento di Pediatria- Unità di Gastroenterologia ed Epatologia Pediatrica-, Roma- Italy, Italy;(3)Ospedale delle mamme e dei bambini - IRCCS 'Burlo Garofolo'-, Gastroenterologia- Endoscopia digestiva e Nutrizione Clinica-, Trieste- Italy, Italy;(4)Ospedale Pediatrico- AO SS Antonio e Biagio e C. Arrigo-, Pediatria ed Unità di Emergenza Pediatrica-, Alessandria -Italy, Italy;(5)Università di Milano BIcocca- Fondazione MBBM c/o Ospedale San Gerardo -, Clinica Pediatrica -, Monza- Italy, Italy;(6)Università del Piemonte Orientale-, Divisione di Pediatria- Dipartimento di scienze della salute-, Novara – Italy, Italy; NUTRIBD
P503: Inflammatory bowel disease video-consulting: a satisfaction survey during the second wave of Covid-19 pandemicsECCO'21 Virtual
Year: 2021
Authors: Todeschini, A.(1);
(1)Policlinico di Bari, U.O. Gastroenterologia Universitaria, BARI, Italy; Contaldo A Lacavalla I Ierardi E Di Leo A & Prinicpi M
P504: Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort studyECCO'21 Virtual
Year: 2021
Authors: Fumery, M.(1);Filippi, J.(2);Abitbol, V.(3);Biron, A.(4);Laharie, D.(5);Serrero, M.(6);Altwegg, R.(7);Bouhnik, Y.(8);Peyrinbiroulet, L.(9);Gilletta, C.(10);Roblin, X.(11);Pineton de Chambrun, G.(12);Vuitton, L.(13);Bourrier, A.(14);Nancey, S.(15);Gornet, J.M.(16);Nahon, S.(17);Bouguen, G.(18);Viennot, S.(19);Pariente, B.(20);Amiot, A.(21);
(1)Amiens University Hospital, Gastroenterology, Amiens Cedex 1, France;(2)Nice University Hospital, Gastroenterology, NIce, France;(3)Cochin Hospital, Gastroenterology, Paris, France;(4)Reims University hospital, Gastroenterology, Reims, France;(5)Bordeaux university hospital, Gastroenterology, Bordeaux, France;(6)Marseille University Hospital, Gastroenterology, Marseille, France;(7)Montpellier University Hospital, Gastroenterology, Montpellier, France;(8)Beaujon Hospital, Gastroenterology, Clichy, France;(9)Nancy University hospital, Gastroenterology, Nancy, France;(10)Toulouse University Hospital, Gastroenterology, Toulouse, France;(11)St Etienne University Hospital, Gastroenterology, Saint-Etienne, France;(12)Montpellier, Gastroenterology, Montpellier, France;(13)Besancon, Gastroenterology, Besancon, France;(14)Saint-Antoine Hospital, Gastroenterology, Paris, France;(15)Lyon Sud Hospital, Gastroenterology, Lyon, France;(16)Saint Louis Hospital, Gastroenterology, Paris, France;(17)Montfermeil Hospital, Gastroenterology, Montfermeil, France;(18)Rennes University Hospital, Gastroenterology, Rennes, France;(19)Caen University Hospital, Caen University Hospital, Caen, France;(20)Lille University Hospital, Gastroenterology, Lille, France;(21)Creteil University Hospital, Gastroenterology, Creteil, France; GETAID
P505: Early therapeutic drug monitoring after induction therapy with infliximab: correlation with intestinal ultrasoundECCO'21 Virtual
Year: 2021
Authors: Nascimento, C.(1);Morão, B.(1);Frias Gomes, C.(1);Cúrdia Gonçalves, T.(2);Castro, F.(2);Moreira, M.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
(1)Hospital Beatriz Ângelo, Gastrenterology, Loures, Portugal;(2)Hospital da Senhora da Oliveira, Gastrenterology, Guimarães, Portugal;(3)Unidade Local de Saúde de Castelo Branco- EPE- Hospital Amato Lusitano, Gastrenterology, Castelo Branco, Portugal;(4)Centro Hospitalar de São João, Gastrenterology, Porto, Portugal;(5)Centro Hospitalar e Universitário de Coimbra, Gastrenterology, Coimbra, Portugal
P506: The Impact of Anxiety in Patients With Inflammatory Bowel Diseases Treated With Biologics during COVID Lockdown. A Comparative Study between Hospitalized and non-hospitalized patientsECCO'21 Virtual
Year: 2021
Authors: Bertani, L.(1,2);Barberio, B.(3);Zanzi, F.(1);Maniero, D.(3);Ceccarelli, L.(4);Marsilio, I.(3);Minciotti, M.(2);Coppini, F.(1);Lorenzon, G.(3);Mumolo, M.G.(4);Zingone, F.(3);Costa, F.(4);Savarino, E.V.(3);
(1)University of Pisa, Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy;(2)Tuscany North West ASL, Massa Apuane Hospital, Massa, Italy;(3)University of Padua, Surgery- Oncology and Gastroenterology - DISCOG, Padua, Italy;(4)Pisa University Hospital, General Surgery and Gastroenterology, Pisa, Italy
P507: Vulvar Crohn’s disease: A challenging diagnosisECCO'21 Virtual
Year: 2021
Authors: Sahar, N.(1);Dahmani, W.(1);Nour, E.(1);Aya, H.(1);Wafa, B.A.(1);Aida, B.S.(1);Ahlem, B.(1);Mehdi, K.(1);Hanene, J.(1);Ali, J.(1);
(1)university hospital of Sahloul, gastroenterology, Sousse, Tunisia
P508: Dose adjustment in patients with moderate to severe ulcerative colitis: results from year 3 of the UNIFI maintenance study long-term extensionECCO'21 Virtual
Year: 2021
Authors: Rowbotham, D.S.(1);Scherl, E.J.(2);Sands, B.E.(3);Panaccione, R.(4);Peyrin-Biroulet, L.(5);Zhang, H.(6);Miao, Y.(6);Leong, R.W.(7);Afif, W.(8);Arasaradnam, R.P.(9);Danese, S.(10);Marano, C.(6);
(1)Auckland City Hospital, Gastroenterology, Auckland, New Zealand;(2)New York Presbyterian Weill Cornell Medical College, Roberts Center for Inflammatory Bowel Disease, New York, United States;(3)Mount Sinai School of Medicine, Henry D. Janowitz Division of Gastroenterology, New York, United States;(4)University of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada;(5)Nancy University Hospital- Université de Lorraine, Department of Gastroenterology, Nancy, France;(6)Janssen Research & Development- LLC, Immunology, Spring House, United States;(7)Concord Repatriation General Hospital, Inflammatory Bowel Disease Clinic, New South Wales, Australia;(8)McGill University Health Centre, Division of Gastroenterology, Montreal, Canada;(9)University Hospital Coventry and Warwickshire, Gastrointestinal Medicine, Coventry, United Kingdom;(10)Instituto Clinico Humanitas, Department of Gastroenterology, Milano, Italy; UNIFI